retatrutide dosing bodybuilding Dosing: Weekly Injections, Clinical Trials & Weight Loss Results Retatrutide: Dosage and Effects on

Accepted: Jan 01, 2024 DOI: Download citation

Gallbladder disease: Cholelithiasis (gallstones) and cholecystitis have been reported with GLP-1 receptor agonist therapies and may also occur with rapid weight loss

Significant Weight Loss Retatrutide has demonstrated remarkable weight loss in clinical trials, with participants achieving up to 24% body weight loss over 48 weeks at higher doses

Patients are monitored throughout treatment

E., Wolski, K., Feng, Q., Gyongyosi, M., Lscher, T

Since tirzepatide is already approved and well known, doctors have a solid basis for talking about how it can be used to treat obesity